OBJECTIVE: To illustrate the Canadian drug regulatory system.METHODS: Literature review and descriptive analysis.RESULTS & CONCLUSIONS: Based on the Canadian health system and drug market,the Canadian drug regulatory system is an integrated system in terms of its regulation on drug approval,price review as well as reimbursement management.

OBJECTIVE:To illustrate the drug expenditure and drug price regulation in Canada for reference by China. METHODS: Literature review and descriptive analysis was conducted. RESULTS & CONCLUSIONS: It was estimated in 2007 the drug expenditure in Canada accounted for 16.8% of national health expenditure, and the per capita drug expenditure was estimated to be 818 Canadian dollars. The regulation of drug price in Canada includes monitoring and reporting of both patented drugs and non-patented drugs. Reference pricing is applied in patented drugs review process, and corresponding methodologies regarding international and domestic comparison are clearly designed.

OBJECTIVE:To compare the cost of 4 kinds of second-line drug treatment regimes(docetaxel, pemetrexed, gefitinib,and erlotinib)for non-small-cell lung cancer(NSCLC). METHODS: The utilization information of medical resources in the NSCLC treatment regimes was collected from experts who were familiar with NSCLC treatment. The costs of 4 kinds of second-line drug treatment regimes were calculated using micro-simulation method. RESULTS: The costs of every cycle period(3 weeks)were 12 237.02 yuan for docetaxel regime, 12 102.82 yuan for gefitinib, 27 614.93 yuan for pemetrexed and 14 272.76 yuan for erlotinib. CONCLUSION: Gifitinib is not inferior to docetaxel in terms of pharmaeconomics for those with 6 months or longer period of anticipated progression-free survival.

OBJECTIVE:To study the relationship between the price-lowering policy and the shortage of low-price essential medicines.METHODS:We expounded the practice of price-lowering policy in China and its effect on the production and circulation of low-price essential medicines,and analyzed the shortage problem of the low-price essential medicines using economic equilibrium analysis.RESULTS:The shortage of low-price essential medicines mainly manifested as shortage of supply,and the price-lowering policy has enlarged the gap between market demand and the supply of low price essential medicines.CONCLUSION:The national essential medicine policy should provide institutional protection for reasonable drug price level as well as the production and supply of low-price essential medicines,and the simple price-lowering policy must evolve to be included in the comprehensive institutional "healthcare reform" strategy.

On the basis of a retrospective summary of the policies for foreign-invested hospitals in China,this paper analyzed the main issues facing wholly foreign-owned hospitals and suggested a basket of strategies to promote the development of such hospitals in China (Shanghai)Pilot Free Trade Zone.

Acupuncture ; education ; trends ; Biomedical Research ; trends ; China ; Humans ; Philosophy

Acupuncture Therapy ; China ; Health Services Accessibility ; Humans ; Public Health

This paper systematically analyzed the concept of patients'trust based on a study of the literatures and compared patients'trust with patients'satisfaction. The conclusion is that patients'trust plays a key role on the quality improvements of medical services.

Eight batches of raw material of pollen preparation——pollen mass have heen investigated in their character,specific pollen rate, abnormal toxicity test and residue of pesticide. These data will avail the quality control of pollen mass and assurance of safety and effect of pollen preparation.

OBJECTIVE:To summarize the experiences of Ningxia's drug tender policy reform in unifying tender operation,price,and distribution("Trinity" reform).METHODS:Review of the reform process with discussion from the perspective of extension of tender policy objective,essential medicine policy as well as existing problems and corresponding countermeasures.RESULTS & CONCLUSIONS:In addition to the functions that Ningxia's "Trinity" reform of drug tender policy solidifies the price-lowering role of drug tender policy and benefits the construction of essential medicine policy,the reform still needs to be improved with regards to some existing problems.